13-107866179-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080396.3(NALF1):c.418G>A(p.Gly140Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000854 in 1,604,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001080396.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NALF1 | NM_001080396.3 | c.418G>A | p.Gly140Ser | missense_variant | 1/3 | ENST00000375915.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NALF1 | ENST00000375915.4 | c.418G>A | p.Gly140Ser | missense_variant | 1/3 | 1 | NM_001080396.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000951 AC: 22AN: 231440Hom.: 0 AF XY: 0.0000783 AC XY: 10AN XY: 127710
GnomAD4 exome AF: 0.0000799 AC: 116AN: 1451866Hom.: 0 Cov.: 33 AF XY: 0.0000928 AC XY: 67AN XY: 721784
GnomAD4 genome AF: 0.000138 AC: 21AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 17, 2021 | The c.418G>A (p.G140S) alteration is located in exon 1 (coding exon 1) of the FAM155A gene. This alteration results from a G to A substitution at nucleotide position 418, causing the glycine (G) at amino acid position 140 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at